BSACI guidance for the implementation of Palforzia® peanut oral immunotherapy in the United Kingdom: A Delphi consensus study (2024)
Attributed to:
MICA: Identifying risks for severe life-threatening allergic reactions to foods (IRIS-Allergy)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/cea.14491
Publication URI: http://dx.doi.org/10.1111/cea.14491
Type: Journal Article/Review
Parent Publication: Clinical & Experimental Allergy
Issue: 7